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Abstract
Background: C-type lectins are a superfamily of Ca
2+ dependent carbohydrate-recognition proteins that play significant
diverse roles in nonself-recognition and clearance of invaders. Though they are well characterized in vertebrates, the study
of the potential function and mechanism of C-type lectins in invertebrate immunity is still in its infancy.
Methodology: A C-type lectin (CfLec-1) from scallop Chlamys farreri, a dominant cultured mollusk species in China, was
selected to investigate its mRNA expression, localization and the possible functions in innate immunity in the present study.
After scallop was stimulated by three typical PAMPs, the mRNA expression of CfLec-1 in hemocytes was poles apart. It was
significantly up-regulated (p,0.01) after scallops were stimulated by LPS or b-glucan, but significantly down-regulated
(p,0.01) after PGN stimulation. The binding ability of recombinant CfLec-1 (designated as rCfLec-1) towards eight PAMPs
was investigated subsequently by PAMPs microarray, which revealed rCfLec-1 could bind LPS, PGN and mannan in vitro,
indicating CfLec-1 served as a PRR involved in the pathogen recognition. Immunofluorescence assay with polyclonal
antibody specific for CfLec-1 revealed that CfLec-1 was mainly located in the mantle and gill of the scallop. CfLec-1 could
bind to the surface of scallop hemocytes and recruited hemocytes to enhance their encapsulation in vitro, and this process
could be specifically blocked by anti-rCfLec-1 antibody. Meanwhile, rCfLec-1 could also enhance the phagocytic activity of
scallop hemocytes against Escherichia coli.
Conclusions: The results clearly suggested that CfLec-1 in C. farreri not only served as a PRR involved in the PAMPs
recognition, but also functioned as an opsonin participating in the clearance of invaders. It is therefore suspected that
CfLec-1 could be an attachment-molecule to nonself-agents acting as an alternative to immunoglobulin in vertebrates.
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Introduction
Innate immune response is a common feature of metazoan
organisms, which protect hosts against pathogens and opportunistic
microbial infections. Invertebrates are devoid of an adaptive
immune system and they exclusively rely on innate immune
reactions for theirs defense [1,2]. The first and crucial step of innate
immuneresponseisto recognize highlyconservedstructurespresent
inalargegroup ofmicroorganismsbutabsentinrespondingspecies,
referring to as pathogen-associated molecular pattern (PAMPs).
And the receptors in innate immune system, which have evolved to
recognize PAMPs, are known as pattern recognition receptors
(PRRs) [3,4]. At least six groups of PRRs, including peptidoglycan
recognition protein (PGRP), Toll-like receptor (TLR), thioester-
containing protein (TEP), lipopolysaccharide and b-1, 3-glucan
binding protein (LGBP), C-type lectin (CTL) and galectin (GALE),
have been identified from invertebrates [5]. Among of them C-type
lectin is a well known PRR which can recognize and bind to
terminal sugars on the microorganisms and takes part in the
immune recognition against pathogens [5,6].
C-type lectins are a superfamily of Ca
2+ dependent carbohy-
drate-recognition proteins, which play significant roles in non-self
recognition and clearance of invaders, either as cell surface
receptors for microbial carbohydrates or as soluble proteins
existing in tissue fluids [5,6]. They involve in several innate
immune responses [7], such as proPO activation [8,9], nodule
formation [10], phagocytosis [11] and antibacterial activity [12].
All the carbohydrate-recognition behaviors of C-type lectins are
benefit from their carbohydrate-recognition domain (CRD) of
,130 amino acid residues [13,14]. In each CRD, there is a
characteristic double-loop stabilized by two highly conserved
disulfide bridges located at the bases of the loops, as well as a set of
conserved hydrophobic and polar interactions. There are four
Ca
2+-binding sites identified from CRDs of different species,
among which the Ca
2+-binding site 2 is structurally conserved and
involved in carbohydrate-binding activity [15].
In recent years, more and more C-type lectins have been
identified from invertebrates, especially from insects and crusta-
ceans [8,10,16–19]. Compared with those in arthropods, research
on mollusk C-type lectins is in its infancy, though several C-type
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believed to involve in immune defence [20,21]. In our previous
study, several C-type lectins genes (CfLec-1 - CfLec-4) were
identified from Zhikong Scallop Chlamys farreri, an important
economic bivalve specie cultured widely in the northern coast of
China, and they were proved to involve in the immune response
against Vibrio anguillarum [22–25], but the possible functions they
performed and the underlined mechanism were still not well
understood. In the present study, CfLec-1 was selected for further
study in order to (1) examine its PAMPs recognition and binding
pattern, (2) detect its localization in the tissues of C. farreri, (3)
characterize the opsonization mediated by CfLec-1, including
encapsulation and phagocytosis, and (4) get further understanding
of the immune system of C. farreri.
Materials and Methods
Ethics statement
The scallops used in the present study are marine cultured
animals, and all the experiments are conducted according to the
regulations of local and central government. Female Wistar rats
were from Qingdao institute for the control of drug products
(Qingdao, China), and the animal experiments were approved by
the Animal Care and Use Committee at Qingdao institute for the
control of drug products with a permit number of SCXK
(Shandong) 20090007, which complied with the National Institute
of Health Guide for the Care and Use of Laboratory Animals.
Immune stimulation of scallop
Adults of scallop C. farreri with an average 55 mm of shell length
were collected from a farm in Qingdao, Shandong Province,
China, and maintained in the aerated seawater at 15uC for a week
before processing.
Two hundred scallops were employed for the PAMPs stimulation
experiment. The scallops were randomly divided into 5 groups and
each group contained 40 individuals. Four groups receiving an
injection of 50 mL phosphate buffered saline (PBS, 0.14 M sodium
chloride, 3 mM potassium chloride, 8 mM disodium hydrogenpho-
sphate dodecahydrate, 1.5 mM potassium phosphate monobasic,
pH 7.4), LPS from Escherichia coli 0111:B4 (Sigma-Aldrich, 0.5 mg
ml
21 in PBS), PGN from Staphylococcus aureus (Sigma-Aldrich,
0.8 mg ml
21 in PBS), and b-glucan from Saccharomyces cerevisiae
(Sigma-Aldrich, 1.0 mg ml
21 in PBS), respectively. The untreated
group was employed as blank group. After treatment, the scallops
were returned to water tanks and 5 individuals were randomly
sampled at 3, 6, 12, 24 and 48 h post-injection. The hemolymphs
were collected, and centrifuged at 500 6g, 4uC for 10 min to
harvest the hemocytes for RNA preparation.
Expression patterns of CfLec-1 post PAMPs stimulation
Total RNA was extracted using Trizol reagent according to the
manufacture’s protocol (Invitrogen). The first-strand synthesis was
c a r r i e do u tb a s e do nP r o m e g aM - M L VR TU s a g ei n f o r m a t i o nu s i n g
the DNase I (Promega)-treated total RNA as template and oligo (dT)-
a d a p t o ra sp r i m e r( T a b l e1 ) .T h er e a c t i o nm i x t u r e sw e r ep e r f o r m e d
at 42uC for 1 h, terminated by heating at 95uCf o r5m i n .c D N Am i x
was diluted to 1:100 and stored at 280uC for subsequent SYBR
Green fluorescent quantitative real-time PCR (RT-PCR).
One pair of gene-specific primer for CfLec-1 (Table 1) was used to
amplify product of 228 bp from cDNA. The PCR product was
sequenced to verify the specificity of RT-PCR. Two b-actin primers,
AF and AR (Table 1), were used to amplify a 94-bp fragment as an
internal control to verify the successful transcription and to calibrate
the cDNA template for corresponding scallop samples.
Real-time PCR amplification was carried out in an ABI 7300
Realtime Thermal Cycler according to the manual (Applied
Biosystems). Dissociation curve analysis of amplification products
was performed at the end of each PCR to confirm that only one
PCR product was amplified and detected. The 2
2ggCT method
was used to analyze the expression level of CfLec-1 [26]. All data
were given in terms of relative mRNA expressed as mean 6 SE
(N=4). The data were subjected to one-way analysis of variance
(one-way ANOVA) followed by an unpaired, two-tailed t-test.
Differences were considered significant at P,0.05 and extremely
significant at P,0.01.
Preparation of recombinant protein of CfLec-1
The strains E. coli BL21(DE3)-pLysS with recombinant plasmid
(pET-32a-CfLec-1) [22] and the negative control pET-32a (Nova-
gen) vector without insert fragment which could express a
thioredoxin (Trx with 66His-tag in the prokaryotic express system),
were incubated in LB medium (containing 50 mg ml
21 ampicillin)
at 37uC with shaking at 220 rpm. When the culture mediums
reached OD600 of 0.5–0.7, the cells wereincubated for 4 additional
hours with the induction of IPTG at the final concentration of
1 mmol L
21. The recombinant protein CfLec-1 and Trx (desig-
nated rCfLec-1 and rTrx) were purified by a Ni
2+ chelating
Sepharose column, pooled by elution with 400 mmol L
21 imidaz-
ole under denatured condition (8 mol L
21 urea). The purified
protein was refolded in gradient urea-TBS glycerol buffer
(50 mmol L
21 Tris–HCl, 50 mmol L
21 NaCl, 10% glycerol,
2 mmol L
21 reduced glutathione, 0.2 mmol L
21 oxide glutathi-
one, a gradient urea concentration of 6, 5, 4, 3, 2, 1, 0 mol L
21
urea, pH 8.0; each gradient at 4uC for 12 h). The resultant proteins
were separated by reducing 15% SDS-polyacrylamide gel electro-
phoresis (SDS-PAGE), and visualized with Coomassie bright blue
R250. The concentration of purified rCfLec-1 and rTrx was
quantified by BCA method [27], respectively. The obtained
proteins were stored at 280uC before use.
Preparation of antibodies and Western blotting analysis
For preparation of antibodies, the renatured protein rCfLec-1
was continued to be dialyzed against ddH2O before it was freeze
concentrated. Trx-tag was removed from the fusion protein by
digestion with enterokinase (NEB). rCfLec-1 (without Trx-tag) was
immuned to 6 weeks old rats to acquire polyclonal antibody as the
method discribed by Cheng [28]. The antiserum was purified by
the Ampure PA kit (Amersham) following the manufacturer’s
protocol, and then the purified Ig was labeled with Cy3 (GE
Healthcare) according to the suggestion of the manufacturers and
used as microarray detection antibody.
After SDS-PAGE, the samples (4 hours after IPTG added) were
electrophoretically transferred onto a 0.45 mm pore nitrocellulose
membrane at 200 mA for 5 h. The membrane was blocked with
Table 1. Primers used in the present study.
Primer Sequence (59—39)
Oligo(dT)-adaptor GGCCACGCGTCGACTAGTACT17
CfLec-1 RTF (forward) CAACCTGTTCTATATCTGCGAG
CfLec-1 RTR (reverse) GATCTGTTGGCTGATTTCAC
b-actin AF (forward) CAAACAGCAGCCTCCTCGT
b-actin AR (reverse) CTGGGCACCTGAACCTTTCGTT
doi:10.1371/journal.pone.0017089.t001
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antibodies at 37uC for 1 h, then washed three times with PBS
containing 0.05% Tween-20 (PBS-T). Antibody binding was
detected with goat-anti-rat Ig-alkaline phosphatase conjugate
(Southern Biotech) diluted 1:4000 in PBS at 37uC for 1 h, and
washed three times with PBS-T. Protein bands were stained with
freshly prepared substrate solution (100 mM NaCl, 100 mM Tris
and 5 mM MgCl2, pH 9.5) containing nitroblue tetrazolium
(NBT, Sigma) and 5-bromo-4-chloro-3-indolyphosphate (BCIP,
Sigma) for 5 min and stopped by washing with distilled water.
Rats’ pre-immune serum was used as negative control.
PAMPs binding assay
The PAMPs binding assay of rCfLec-1 was performed by the
method of PAMPs microarray according to the previous report
with modification [29,30]. Briefly, a high-precision robot designed
to produce cDNA microarrays (GMS 417 Arrayer; Genetic
Microsystems, Inc., Woburn, MA) was utilized to spot PAMPs
antigens onto the glass slides precoated with nitrocellulose polymer
(FAST Slides; Schleicher & Schuell, Keene, NH). PAMPs were
dissolved in PBS in concentrations as specified in Table 2, and
printed with spot sizes of ,150 mm and center to center intervals
of 150 mm. The printed PAMPs microarrays were air-dried and
stored at 4uC without desiccant before application. Immediately
before use, the printed PAMPs microarrays were rinsed with PBS-
T and then blocked by incubating the slides in 3% BSA in PBS at
37uC for 1 h. After three times’ washing with PBS-T, 20 mlo f
rCfLec-1 in the concentration of 100 mgm L
21 was added onto
the microarrays, and the same dose of rTrx was set as a control.
After incubated at 18uC for 2 h, the microarrays were washed
three times with PBS-T, and then 20 ml of Cy3-conjugated anti-
CfLec-1 antibody (1:300 diluted in PBS) was added and incubated
Table 2. Characteristic of the samples print on the microarrays.
Number Sample name Source Concentration Purpose
a lipopolysaccharides E. coli (Sigma) 1 mg mL
21 PAMP
b peptidoglycan S. aureus (Sigma) 1 mg mL
21 PAMP
c yeast glucan S. cerevisiae (Sigma) 1 mg mL
21 PAMP
d b-1,3-glucan Euglena gracilis (Sigma) 1 mg mL
21 PAMP
e mannan S. cerevisiae (Sigma) 1 mg mL
21 PAMP
f lipoteichoic acids S. aureus (Sigma) 1 mg mL
21 PAMP
g CpG ODN Digested from our constructed plasmid 20 mgm L
21 PAMP
h poly I:C Sigma 1 mg mL
21 PAMP
i rabbit anti-rat IgG rabbit 0.1 mg mL
21 Positive control
j PBS-glycerol - 40% (v/v) Negative control
doi:10.1371/journal.pone.0017089.t002
Figure 1. Temporal expression of CfLec-1 mRNA relative to b-actin was analyzed by realtime PCR in scallop hemocytes after LPS,
PGN, b-glucan and PBS challenge for 3, 6, 12, 24 and 48 h. The values are shown as mean 6 SE (N=4). (*: P,0.05, **: P,0.01).
doi:10.1371/journal.pone.0017089.g001
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microarrays were obtained using a laser chipscanner (Capitalbio
Corporation, China) at 532 nm, and analyzed with EcoscanCHS
software to quantify florescence intensity.
The dose-dependent PAMPs binding activity of rCfLec-1 was
measured according to previous report with modification [31].
Briefly, 20 mg of PAMPs were used to coat 96-well microtiter plate
(Costar)in100 ml ofcarbonate-bicarbonatebuffer (50 mM,pH 9.6)
and incubated overnight at 4uC. The wells were washed three times
with PBS-T and then blocked with 200 ml of 3% BSA in PBS at
37uC for 1 h. The plate was washed three times and 100 ml several
concentrations of rCfLec-1 was then added to the wells in the
presence of 5 mM CaCl2 and 0.1 mg ml
21 BSA. The same
concentration of rTrx was used as a control. After incubated at
18uC for 2 h, the plate was washed three times with PBS-T, and
then 100 ml of rats’ immune serum of rCfLec-1 (diluted 1:1000 in
PBS) was added to the wells as the first antibody. After incubationat
37uC for 1 h,the plate waswashedagainand100 ml ofgoat-anti-rat
Ig-alkaline phosphatase conjugate (Southern Biotech) diluted
1:4000 in PBS was added as second antibody and incubated at
37uC for 1 h. After the last washing, 100 ml of 0.1% (w/v) p-
nitrophenyl phosphate (pNPP, Sigma) in 50 mM carbonate-
bicarbonate buffer (pH 9.8) containing 0.5 mM MgCl2 was added
to each well and incubated at room temperature in dark for 30 min.
The reaction was stopped by adding 50 ml of 2 M NaOH per well
and the absorbance was measured with an automatic ELISA reader
at 405 nm (Molecular Devices). The wells filled with 100 mlo fT B
were used as blank. Non-immune rat serum instead of immune
serum as first antibody was set as negative control. Each experiment
was repeated in triplicate. Samples with P (sample) – B (blank)/N
(negative) – B (blank) .2.1 were considered positive.
Immunofluorescence detection of CfLec-1 in tissues
The hemolymph from five scallops (about 0.5 ml per individual)
collected by a syringe containing pre-cooled (4uC) modified
Alsever solution (0.12 M glucose, 0.03 M sodium citrate, 9 mM
EDTA and 0.38 M NaCl, pH 7.2) as an anticoagulant were
pooled together and immediately centrifuged at 500 6g, 4uC for
10 min to harvest the hemocytes. The hemocyte pellet was
resuspended in PBS, and deposited on clean slides (a drop on each)
in the wet chamber for 1 h. After hemocytes settled in monolayers
on slides, the PBS was sipped up using a filter paper, followed by
fixing the slides in acetone for 15 min before being stored at
220uC until use.
The gill, adductor muscle, gonad, hepatopancreas, mantle and
kidney of scallops dissected according to Lin [32] were embedded
in tissue freezing medium (Leica) and stored at 220uC.
Continuous 7 mm thick frozen sections of each sample were cut
using a Leica CM1900 cryostat at 220uC and transferred onto
glass slides, which were pre-coated with gelatin solution (Gelatin
5gL
21, CrK(SO4)2 ?12H2O 0.5 g L
21) and fixed with pre-cooled
acetone for 15 min. These tissues cryosections were stored at
220uC until use.
The slides of hemocytes and tissues were covered with 20 ml
antibody of rCfLec-1 (diluted 1:1000 in PBS) as primary antibody
and incubated at 37uC for 1 h in a moisture chamber. After three
times washing with PBS-T, the slides were incubated at 37uCf o r
1 h with fluorescein isothiocyanate conjugated goat anti-rat
immunoglobulins serum diluted at 1:200 with PBS (Southern
Biotech), contained 1 mgm l
21 Evan’s blue dye (EBD, Fluka) as
the counterstain. Finally, the slides were washed three times and
mounted in buffered glycerin for observation by fluorescence
microscope. Rats’ preimmune serum was used as negative
control.
In vitro encapsulation
In vitro encapsulation assay was performed according to previous
report [33]. Briefly, Ni-NTA agarose beads (Qiagen) were
equilibrated in TBS containing 5 mM CaCl2, and then renatured
His-tagged rCfLec-1 and rTrx (as a control protein) were added
and incubated with agarose beads in a 1.5 ml tube with shaking at
4uC overnight, respectively. Protein-coated beads were washed
with TBS four times, each for 5 min, and suspended in TBS at
100–120 beads per microliter. A 48-well cell culture plate (Costar)
was treated with 1% agarose (Qiagen). The hemolymph was
withdrawn by a sterile syringe from the adductor muscle and
simultaneously diluted (1:3) in anticoagulant. Hemocytes were
suspended in 200 ml of Leibovitz L-15 medium (Sigma). The
diluted hemolymph was added to each well of the agarose-coated
plate. Hemocytes were allowed to settle down for at least 10 min,
then 1 ml (100–120 beads) of the protein-coated agarose beads was
added to each well, and the plate was incubated at 18uC.
Encapsulation of the agarose beads was observed after 6 and 24 h
incubation, respectively. For each recombinant protein, assay was
performed in three different wells for statistic analysis.
To test whether in vitro encapsulation was specifically incited by
C-type lectin, 5 ml protein-coated beads were placed in a
microcentrifuge tube containing 50 ml of rat anti- rCfLec-1
Figure 2. SDS-PAGE and Western-blot analysis of rCfLec-1. Lane
1: protein molecular standard; lane 2: negative control for rCfLec-1
(without induction); lane 3: induced rCfLec-1; lane 4: purified rCfLec-1;
lane 5: production of rCfLec-1 digested by enterokinase; lane 6: rCfLec-1
with out Trx tag; lane 7: western-blot of rCfLec-1.
doi:10.1371/journal.pone.0017089.g002
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incubated at 4uC overnight with shaking. Then the beads were
washed with TBS and suspended in 5 ml TBS. In vitro
encapsulation assay was performed as described above.
Phagocytosis assay
Phagocytosis assay was performed according to previous
method with modification [34]. Briefly, hemolymph was collected
from five scallops with a syringe, and mixed immediately with
equal volume of pre-chilled anticoagulant (Tris-HCl 50 mM;
glucose 2%, NaCl 2%; EDTA 20 mM; pH 7.4), and then
centrifuged at 800 g for 10 min. The hemocytes were resuspended
with 200 ml TBS buffer (Tris-HCl 50 mM; CaCl2 5 mM),
100 mgm L
21 rTrx in TBS buffer and 100 mgm L
21 rCfLec-1
in TBS buffer, respectively. The hemocytes were incubated at
18uC for 30 min, then 5 ml E. coli (OD600=0.4, suspended in Tris-
HCl) was added into each hemocytes suspension, and incubated at
18uC for another 1 h. About 50 ml of the mixture was mounted
onto a glass slide and put into a moist chamber for 1 h. The slides
were washed with Tris-HCl, air-dried, fixed with methyl alcohol
and stained with Giemsa. The phagocytic activity of hemocyte
attached to the slide was measured using a light microscope. Two
hundred hemocytes on each slide were counted. Phagocytic rate
(PR) and phagocytic index (PI) representing the phagocytic
activities were expressed as following: PR= (phagocytic hemo-
cytes)/(total hemocytes)6100%; PI=average number of bacteria
in phagocytic hemocyte. For each treatment, assay was performed
in three different slides for statistic analysis.
Results
The mRNA expression patterns post PAMPs stimulation
Real-time PCR was used to monitor the mRNA expression of
CfLec-1 transcripts in adult animals stimulated by three typical
PAMPs (Fig. 1). In the LPS stimulated group, the mRNA
expression of CfLec-1 was significantly (P,0.01) up-regulated,
Figure 3. PAMPs binding assays. (A) PAMPs binding assay with microarrays. Samples were print onto the glass slides as the order showed in
Table 2. The PAMPs microarrays were blocked by BSA, then rCfLec-1was added, and rTrx was set as a control. The interaction was detected by Cy3-
conjugated anti-CfLec-1 antibody. (B) The dose-dependent of PAMPs binding by the method of ELISA. Plates were coated with 20 mg of PAMPs,
respectively, which were washed and incubated with several concentrations of rCfLec-1 and rTrx in the presence of 5 mM CaCl2 at 18uC for 3 h and
detected with rat polyclonal antiserum and goat-anti-rat Ig-alkaline phosphatase conjugate. Samples with P/N.2.1 were considered positive. Results
are representative of average three such experiments.
doi:10.1371/journal.pone.0017089.g003
CfLec-1 Mediating Recognition and Opsonization
PLoS ONE | www.plosone.org 5 February 2011 | Volume 6 | Issue 2 | e17089and it reached the maximal level (5.9-fold compared with blank
group) at 12 h after challenge. Similar significant (P,0.01) up-
regulation expression of CfLec-1 transcript was also observed in the
b-glucan stimulated group, though the maximal level, which was 6.4-
fold compared with blank group, was observed at 24 h after b-glucan
stimulation. On the contrary, the mRNA expression in the PGN
stimulated group was significantly (P,0.01) down-regulated, and it
e x h i b i t e dal e v e lo f0 . 1 4a n d0 . 1 7 - f o l dc o m p a r e dw i t hb l a n kg r o u pa t
3 h and 6 h after stimulation, respectively, then the expression
increased to the original level and last to 48 h after challenge. In the
control group, there was no significant change of CfLec-1 expression
during the whole experiment after PBS injection.
Preparation of recombinant protein and western blotting
analysis
After IPTG induction, the whole cell lysate of E. coli BL21 (DE3)-
pLysS with pET-32a-CfLec-1 was analyzed by SDS-PAGE. A
distinct band with molecular weight of ,40 kDa was revealed,
which was consistent with the predicted molecular mass (Fig. 2, line
3 and 4). Meanwhile, the transformant with parent vector expressed
a unique 20 kDa product representing rTrx (data not shown).
To develop antibody, fusion protein rCfLec-1 was digested with
enterokinase to remove the Trx-tag. Distinct band with molecular
weight of ,25 kDa was observed in the SDS-PAGE of
enterokinase digested mixture, which was consisted with the
theoretical molecular weight of CfLec-1. The other bands of 14–
17 kDa were the disgested Trx (Fig. 2, line 5). The purified protein
(Fig. 2, line 6) was used to prepare antibody.
Western blotting was carried out to identify the specificity of
antibody. A clear reaction band of CfLec-1 with high specificity
was revealed (Fig. 2), and few band of non-specific was visible
(Fig. 2, line 7). As negative control, no visible reaction band was
detected in group of rats’ pre-immune serum (data not shown).
PAMPs binding assay
PAMPs binding assay was performed by the method of PAMPs
microarrays, and the binding activity was calculated by the signal
value of fluorescence. The rCfLec-1 could bind PGN and LPS
obviously with intense signal value of fluorescence, bind mannan
weakly with faint signal value of fluorescence. It could not bind
other PAMPs including yeast glucan, b-1,3-glucan, LTA, CpG
ODN and poly I:C (Fig. 3, A, b). As a protein control, rTrx could
not bind any PAMPs used in this experiment (Fig. 3, A, c).
The dose-dependent PAMPs binding activity of rCfLec-1 was
examined by the method of ELISA. The binding activity was
recorded as P/N at 405 nm, and the samples with P/N .2.1 were
considered as positive. All the value of P/N were higher then 2.1 at
a lower concentration of rCfLec-1 (1.56 mgm l
21) in each PAMP
group, and the values were increased corresponding with the
increasing of rCfLec-1 concentration (Fig. 3, B), which suggesting
the binding activities of rCfLec-1 towards PGN, LPS and mannan
exhibited dose-dependent effect. As a protein control of C-type
lectin, rTrx could not bind any PAMPs used in this experiment
(data not shown).
Immunofluorescence detection of CfLec-1 in tissues
Localization of endogenous CfLec-1 in different tissues was
detected by the method of immunofluorescence. CfLec-1 was
observed on the surface of scallop hemocytes (Fig. 4, a), though it
was predicted to be secreted into hemolymph. Besides, CfLec-1
was also detected to be located in the mantle (Fig. 4, b) and gill
(Fig. 4, c). No fluorescence staining was observed in other tissues
detected, including kidney, gonad, hepatopancreas and muscle
(data not shown). There was no fluorescence staining was observed
in negative control groups (Fig. 4, d, e and f).
In vitro encapsulation
To investigate whether rCfLec-1 could initiate encapsulation,
an in vitro encapsulation assay using protein-coated agarose beads
was performed. Most of the beads (62%) coated with rCfLec-1
were encapsulated by scallops’ hemocytes within 6 h of incubation
(Fig. 5, A, a; B), while few beads (13%) coated with rTrx were
encapsulated (Fig. 5, A, d; B). After 24 h of incubation, the rates of
encapsulated beads coated with rCfLec-1 increased to 75.6%,
Figure 4. Localization of endogenous CfLec-1 in different tissues. Hemocytes or 7 mm thick frozen sections of gill, adductor muscle, gonad,
hepatopancreas, mantle and kidney were fixed with acetone and then incubated with rat polyclonal antiserum to CfLec-1. Binding of antibody to
CfLec-1 was visualized by FITC-labeled secondary antibody (green), and the whole tissues were stained with EBD (red). a and d: hemocytes,
bar=10 mm; b and e: mantle, bar=50 mm; c and f: gill, bar=50 mm.
doi:10.1371/journal.pone.0017089.g004
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(Fig. 5, B).
To test whether enhanced encapsulation by rCfLec-1 was
caused by direct interaction between rCfLec-1 and hemocyte
surface molecules, lectin-coated beads were pre-incubated with rat
polyclonal antibody to block the surface. After pre-incubation of
antibody with the lectin-coated beads, the adhesion of hemocyte
was blocked effectively (Fig. 5, A, c).
Phagocytosis assay
CfLec-1 could significantly enhance the phagocytic activity of
scallop hemocytes (Fig. 6). The phagocytized E. coli was clearly
observed in the cytoplasm of the hemocytes (Fig. 6, a). Compared
with Tris-HCl and rTrx, rCfLec-1 significantly enhanced
(P,0.05) the phagocytic activity against E. coli, both in phagocytic
rate and phagocytic index. The phagocytic rate in rCfLec-1 group
was 41.7%, while that in Tris-HCl and rTrx group were 15% and
16.7%, respectively (Fig. 6, b). And the phagocytic index was also
increased from 1.64 in Tris-HCl group to 3.62 in rCfLec-1 group
(Fig. 6, c).
Discussion
C-type lectins play significant roles in both adaptive immunity
and innate immunity to defense against pathogen infection
[7,35,36] by involving in various immune responses, such as
pathogen recognition [37–39], cellular adhesion [40–43], antigen
uptake [44,45] and complement pathway activation [38,46,47].
However, to our knowledge, the possible immune functions and
the underlined mechanism of mollusk C-type lectin are still not
well understood. In the present study, one of the C-type lectins
from C. farreri, CfLec-1, was selected to investigate its functions in
PAMPs recognition and opsonization. The results clearly indicated
that CfLec-1 not only served as a PRR involving in the PAMPs
recognition, but also functioned as an opsonin participating in the
clearance of invaders.
Immune recognition, which discriminates self from the
potentially harmful non-self, is the premier and crucial step in
the innate immunity. The predominant PAMPs recognition and
binding ability of C-type lectin make it an indispensable molecule
in the first defense line against pathogen infection [22,25]. In
invertebrates,several C-type lectins have heen characterized and
their mRNA expression could be induced by the stimulation of
PAMPs [17,48,49]. In the present study, the mRNA expression of
CfLec-1 was significantly up-regulated after scallops were
stimulated by LPS or b-glucan, indicating CfLec-1 was involved
in the immune response induced by these two PAMPs. PAMPs
binding assay revealed that rCfLec-1 could bind LPS from Gram-
negative bacteia and PGN from Gram-positive bacteria, indicating
that CfLec-1 could recognize PAMPs and served as PRR.
Whereas, rCfLec-1 could not bind b-glucan, though mRNA
expression of CfLec-1 was up-regulated significantly after b-glucan
injection. The results reminded that CfLec-1 was involved in the
recognition of b-glucan, but it could not bind this kind of PAMP
independently. Other molecules are probably needed for it to bind
b-glucan. Interestingly, rCfLec-1 exhibited strong binding activity
towards PGN in vitro, but PGN stimulation significantly down-
regulated the mRNA expression of CfLec-1. These phenomena
tempted us to suspect that the involvement of CfLec-1 in PGN
recognition was sophisticated and further research was still needed
to better understand the mechanism.
The sugar recognition mediated by C-type lectins benefits from
their carbohydrate-recognition domain (CRD) of ,130 amino
acid residues [13,14]. The CRDs exhibit conservative character-
istic in structure, and in each CRD there are a characteristic
double-loop stabilized by two highly conserved disulfide bridges,
and a Ca
2+ binding sites 2 which is involved in carbohydrate
binding [15]. C-type lectins can bind carbohydrate in a specific
manner, which is proved to be determined by the position of
Figure 5. rCfLec-1 promotes encapsulation by scallop hemo-
cytes. Nickel agarose beads coated with rCfLec-1, or rTrx were
incubated with scallop hemocytes. Encapsulation of the protein-coated
beads was observed by microscopy after 6 and 24 h incubation. rCfLec-
1-coated agarose beads were pre-incubated with antibody of rCfLec-1,
and encapsulation of the antibody-bound beads was performed as
above and observed. (A) Protein-coated beads were encapsulated by
scallop hemocytes, and hemocyte encapsulation of the lectin-coated
beads was block by antiserum specific for rCfLec-1, bar=50 mm. (B) The
numbers of encapsulated at 6 h and 24 h beads. The columns represent
the mean of three individual counts 6 S. E. M.
doi:10.1371/journal.pone.0017089.g005
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2+-binding site 2 of CRDs.
The CRDs with EPN (Glu-Pro-Asn) motif binds mannose or similar
sugar, whereas the QPD (Gln-Pro-Asp) motif prefers galactose or
similar sugar [50]. The potential motif in the CRDs of CfLec-1 is
EPD, where an Asp (D) substitutes for Asn (N) in the third position.
The EPD motif is common in lectins from C. farreri, such as the CRD
fromCfLec-2,CRD2fromtheCfLec-3andtheCRD1fromCfLec-4
[22–24]. Structurally, with the substitution by Asp, a hydrogen bond
donor is replaced with an acceptor. But our present work indicated
that this replacement had no effect on activity of PAMPs binding.
Similar results were also reported in the cotton bollworm C-type
lectin [11]. It was suspected that the PAMPs binding features of
invertebrates C-type lectins was more complicated, and other sites in
CRDs might also be involved in PAMPs binding.
Different from the broad tissue distribution of other invertebrate
C-type lectins, CfLec-1 exhibited a specific distribution profile, and
it was located in mantle and gill of the scallop. Mantle is the organ
that scallop protrudes out of the shell, and gill takes the
responsibility to seize oxygen and alga from the seawater, and the
presence of CfLec-1 in these two organs may due to their frequently
contactwithpathogens.Consideringthelargenumberofbacteriain
the aquatic environment, this expression of CfLec-1 in susceptible
organ suggests the important roles for this molecule in defense of
scallops against bacterial infections. In addition, CfLec-1 could also
bind to the surface of hemocytes, though it was predicted to be
secreted intohemolymph with the instruction of signal peptide. This
was similar to some other invertebrates C-type lectins [51,52], and
such binding was believed to be necessary for the opsonization C-
type lectin mediated in invertebrates against invaders [53].
Opsonins are host-derived proteins that can increase the
efficiency of phagocytosis and diversify the functional repertoire
of phagocytes [54,55]. In vertebrates, two archetypical opsonins –
complement fragment C3bi which binds nonspecifically to the
surface of foreign particles, and immunoglobulins (Igs) which
attach to the target particle by recognizing specific surface epitopes
– both have been extensively characterized [54]. Though be
devoid of C3bi and Igs in invertebrates, similar opsonization is also
reported to be mediate by other molecule, for example PGRP-LC,
a peptidoglycan recognition protein is involved in phagocytosis of
Gram-negative bacteria in S2 cells [56]. In invertebrates,
encapsulation and phagocytosis are frequently observed opsoniza-
tion against parasite and bacteria, respectively. Several C-type
lectins from invertebrates were reported to mediate encapsulation
or phagocytosis, such as Immulectins in tobacco hornworm [33]
and C-type lectin in cotton bollworm [11]. Phagocytosis is initiated
by the binding of bacteria to phagocytes, and the process is
facilitated by C3bi or specific Igs in vertebrate. In our present
study, CfLec-1 could recognize and bind the bacteria component,
as well as bind to the surface of hemocytes, and the multi-directed
binding is suspected to be responsible for the phagocytosis
mediated by CfLec-1. Encapsulation is another opsonization that
is restricted to invertebrates in defense against foreign bodies too
large for phagocytosis by individual hemocytes [57], and such
immune response requires coordination of both cellular and
humoral factors [58–60]. Similar to phagocytosis, the coordination
of CfLec-1 and hemocytes recruits hemocytes and promote
hemocytes encapsulation in our present study. These results
indicate that CfLec-1 from C. farreri triggers the opsonization of
hemocytes against invaders, and it is therefore generally expected
that scallop’s C-type lectin that is attachment-molecules to non-
self-agents act as an alternative to Ig. Since there is no antibody-
mediated immunity in mollusk, C-type lectin with diverse
specificities may function as non-clonal effectors in the scallop
immune system. Taking the PAMPs binding ability of CfLec-1
into consider, we suspected that CfLec-1 involved in immune
response against invader with the following mechanism: CfLec-1
firstly bond to the surface of hemocytes, subsequently recognized
and bond the invader target on the specific PAMPs, and finally the
opsonizations were triggered as a result of the coordination of both
cellular and humoral factors.
In our previous studies, 5 C-type lectins have been identified
from Zhikong scallop C. farreri, and all of them can be induced by
Listonella anguillarum or PAMPs stimulation, indicating that they
might involve in the immune responses against the invaders.
However, the C-type lectins exhibited agglutination towards
different bacteria, for instance CfLec-2 agglutinated Gram-positive
bacteria Staphylococcus haemolyticus, while CfLec-3 agglutinated
Gram-negative bacteria Pseudomonas stutzeri as well as CfLec-5
agglutinated fungi Pichia pastoris. It was suggesting that the different
C-type lectin in C. farreri might mediate immune response towards
different pathogen through specific PAMPs recognition [22-25].
Furthermore, CfLec-2 could mediate cellular adhesion to enhance
encapsulation of hemocytes, which was similar to CfLec-1, but it
could not mediate phagocytosis [53]. All the results collectively
indicated that C-type lectins in scallop were a superfamily of
diverse proteins with specificity in recognition, and complemen-
tarity in function, which provided a prominent immune defense
network for scallop against invaders.
Figure 6. Phagocytosis enhanced by rCfLec-1. The hemocytes were resuspended with TBS buffer, rTrx in TBS buffer and rCfLec-1 in TBS buffer,
respectively. The hemocytes were incubated for 30 min, then E. coli was added into each hemocytes suspension for another 1 h. The mixture was
mounted onto a glass slide and stained with Giemsa. The phagocytic activity of hemocyte was measured using a light microscope. Two hundred
hemocytes on each slide were counted. Phagocytic rate (PR) = (phagocytic hemocytes)/(total hemocytes)6100%; phagocytic index (PI) =average
number of bacteria in phagocytic hemocytes. For each treatment, assay was performed in three different slides for statistic analysis.
doi:10.1371/journal.pone.0017089.g006
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